Endoluminal recanalization in a patient with phlegmasia cerulea dolens using a multimodality approach-a case report
Stephanie C Lin1, Albeir Mousa, Joshua Bernheim
1Department of Vascular Surgery, New York Presbyterian Hospital, Cornell University, Weill Medical School and Columbia University, College of Physicians and Surgeons, New York, NY 10021, USA.
Insights
Phlegmasia cerulea dolens, a severe deep venous thrombosis, requires aggressive treatment. A multimodality endovascular approach using pharmacologic thrombolysis and balloon venoplasty, with argatroban for anticoagulation, successfully treated a patient with heparin-induced thrombocytopenia, salvaging the limb.
Area of Science:
- Vascular Surgery
- Interventional Radiology
- Hematology
Background:
- Phlegmasia cerulea dolens (PCD) is a critical condition characterized by extensive deep venous thrombosis (DVT).
- PCD necessitates urgent intervention to prevent limb loss.
- Managing DVT in patients with heparin-induced thrombocytopenia (HIT) presents a significant clinical challenge.
Observation:
- A patient presented with extensive iliocaval and femoral DVT, indicative of PCD.
- The patient had a recent history of heparin-induced thrombocytopenia (HIT), complicating anticoagulation choices.
- Standard heparin anticoagulation was contraindicated due to HIT.
Findings:
- A combined endovascular approach involving catheter-directed pharmacologic thrombolysis and balloon venoplasty was employed.
- Argatroban, a direct thrombin inhibitor, was used for anticoagulation, serving as a safe alternative to heparin.
- This multimodality treatment successfully resolved the venous occlusion and preserved limb viability.
Implications:
- This case demonstrates the efficacy of a combined endovascular strategy for PCD in patients with HIT.
- Pharmacologic thrombolysis and mechanical interventions offer a viable treatment option when heparin is contraindicated.
- Successful limb salvage in complex DVT cases highlights the importance of tailored anticoagulation and advanced endovascular techniques.
Abstract:
Phlegmasia cerulea dolens is a limb-threatening form of deep venous thrombosis and should be treated aggressively. The authors report a patient who presented with iliocaval and femoral deep venous thrombosis and posed an additional therapeutic challenge based on a recent history of heparin-induced thrombocytopenia. Catheter-directed pharmacologic thrombolysis and balloon venoplasty were applied in treatment. The direct thrombin inhibitor argatroban was used in place of heparin for concurrent anticoagulation. This multimodality endovascular approach (chemical and mechanical interventions) was successful in relieving the venous occlusion and salvaging the limb, while maintaining appropriate treatment for heparin-induced thrombocytopenia.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Varicose Veins II: Diagnostic Studies and Interprofessional Care
